Hypothalamic-pituitary-adrenal axis and cardiovascular disease

Stress and Cardiovascular Disease

Volumn 9781848824195, Issue , 2012, Pages 71-87

  Kaltsas, Gregory ^a   Zannas, Anthony S ^b   Chrousos, George P ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Cardiovascular disease; Effects on the immune system; Glucocorticoid circulation; Glucocorticoid metabolism; Glucocorticoid receptor (GR); Hypothalamic Pituitary Adrenal axis; Stress and cardiovascular risk factors; Stress response; Stress system

Indexed keywords

EID: 84866912460     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-419-5_5     Document Type: Chapter

References (44)

1. Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA. 1992;267:1244-1252.
2. Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:32-36.
3. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamopituitaryadrenocortical axis. Trends Neurosci. 1997;20(2):78-84.
4. Kvetnasky R, Pacak K, Sabban EL, et al. Stressor specificity of peripheral catecholaminergic activation. Adv Pharmacol. 1998;42:556-560.
5. Bhatnagar S, Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience. 1998;84(4):1025-1039.
6. Dallman MF, Bhatnagar S, Viau V. Hypothalamic-pituitary-adrenal axis. In: Fink G, ed. Encyclopedia of Stress. 1st ed. London: Academic; 2007:421-427.
7. Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotrophin releasing hormone perspective. Endocrinol Metab Clin North Am. 1992;21: 833-858.
8. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotrophin-releasing factor. Endocr Rev. 1986;7(4):351-378.
9. Lamberts SWJ, Verleun T, Oosterom R, et al. Corticotropin releasing factor and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab. 1984;58:298-303.
10. Engler O, Pham T, Fullenon MJ, et al. Studies of the secretion of corticotropin releasing factor and arginine-vasopressin into hypophyseal portal circulation of the conscious sheep. Neuroendocrinology. 1989;49:367-381.
11. Palkovits M, Young WS, Kovacs K, Toth ZS, Makara GB. Alterations in corticotropinreleasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Neuroscience. 1998;85(1):135-147.
12. Wong ML, Licinio J, Pasternak KI, Gold PW. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in sity hybridization histochemistry. Endocrinology. 1994;135:2275-2278.
13. Potter E, Sutton S, Donaldson C, et al. Distribution of corticotrophin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA. 1994;91(19): 8777-8781.
14. Gray TS. Amygdala: role in autonomic and neuroendocrine responses to stress. In: McCubbin A, Kaufmann PG, Nemeroff CB, eds. Stress, Neuropeptides and Systemic Disease. New York: Academic; 1989:37-53.
15. Roth RH, Tam SY, Ida Y, Yang J, Deutsch AY. Stress and the mesocorticolimbic dopamine systems. Ann N Y Acad Sci. 1988;537:138-147.
16. Mcewen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873-904.
17. Dunn AJ, Berridge CW. Physiological and behavioural responses to corticotropin-releasing factor: is CRF a mediator of anxiety or stress responses? Brain Res Rev. 1990;15:71-100.
18. Shibasaki T, Imaki T, Hotta M, et al. Psychological stress increases arousal through brain corticotrophin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion. Brain Res. 1993;618:71-75.
19. Habib KE, Weld KP, Rice KC, et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA. 2000;97:6079-6084.
20. Smith GW, Aubry JM, Dellu F, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20:1093-1102.
21. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
22. Bailey JL, Wang X, Price SR. The balance between glucocorticoids and insulin regulates muscle proteolysis via ubiquitin-proteasome pathway. Miner Electrol Metab. 1999;25:220-223.
23. Breuner CW, Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J Endocrinol. 2002;175(1):99-112.
24. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711-1723.
25. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17(3):245-261.
26. Lu NZ, Cidlowski JA. The origin and functions of multiple human glucocorticoid receptor isoforms. Ann N Y Acad Sci. 2004;1024:102-123.
27. Pujols L, Mullol J, Perez M, et al. Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Resp Cell Mol. 2001;24(1):49-57.
28. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci. 1998;851:311-335.
29. Chamandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005;67:259-284.
30. Magnuson MA, Quinn PG, Granner DK. Multihormonal regulation of phosphoenolpyruvate carboxykinase-chloramphenicol acetyltransferase fusion genes. Insulin's effects oppose those of cAMP and dexamethasone. J Biol Chem. 1987;262(31):14917-14920.
31. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-871.
32. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet. 1997;349(9060):1210-1213.
33. Girod JP, Brotman DJ. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res. 2004;64:217-226.
34. Stewart PM, Krozowski ZS. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm. 1999;57: 249-324.
35. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
36. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle aged men. JAMA. 2002;288:2709-2716.
37. Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329-339.
38. Hauner H, Schmid P, Pfeifer EF. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab. 1987;64:832-835.
39. Ramsay TG. Fat cells. Endocrinol Metab Clin N Am. 1996;25:847-870.
40. Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol. 1997;79: 2-9.
41. Mangos GJ, Walker BR, Kelly JJ, et al. Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens. 2000;13:1155-1160.
42. Ullian ME. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res. 1999; 41:55-64.
43. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
44. Venihaki M, Dikkes P, Carrigan A, Karalis KP. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest. 2001;108:1159-1166.